Utilization of thioridazine combined with hydergine in the treatment of incipient mental disturbances in cerebral atherosclerosis.
D000368:Aged; D000553:Ambulatory Care; D004359:Drug Therapy, Combination; D004877:Ergoloid Mesylates / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000150:complications*; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy* / Q000209:etiology; D008875:Middle Aged; D013881:Thioridazine / Q000009:adverse effects / Q000627:therapeutic use*
D004877:Ergoloid Mesylates; D013881:Thioridazine